Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001715636 | SCV001942870 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807520 | SCV002054526 | benign | Developmental and epileptic encephalopathy, 11 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807521 | SCV002054527 | benign | Episodic ataxia, type 9 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807519 | SCV002054528 | benign | Seizures, benign familial infantile, 3 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594551 | SCV005087298 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 91% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 85. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001715636 | SCV005239610 | benign | not provided | criteria provided, single submitter | not provided |